EUVIMEDEUVIMED entdecken
Crossref

Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy

Jia-Xian Li, Na Shu, Yao-Jun Zhang, Qi-Song Tong, Ling Wang iD, Jing-Yang Zhang, Jin-Zhi Du iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c01563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Jia-Xian Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, South China University of Technology, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Prodrugs, Immunotherapy, Imidazoles, Nanoparticles. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, China Postdoctoral Science Foundation, Guangzhou Municipal Science and Technology Program key projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsImmunotherapyImidazolesNanoparticlesAnimalsMiceFemaleMice, Inbred BALB CCell Line, TumorHumansTumor-Associated MacrophagesAntineoplastic AgentsRAW 264.7 CellsPolyethylene GlycolsTumor MicroenvironmentDendrimersMacrophages

Stichwörter der Autor:innen

cancer immunotherapydrug deliverymacrophage repolarizationnanoparticlespolymeric prodrugtumor-associated macrophages

Substanzen

ProdrugsImidazolesresiquimodAntineoplastic AgentsPolyethylene GlycolsDendrimers

Autor:innen und Institutionen

  • School of Medicine, South China University of Technology, Guangzhou 510006, China.
  • School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 511442, China.
  • School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.
  • National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou 510006, China.
  • Innovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou 510006, China.

ORCID-Profile: Ling Wang, Jin-Zhi Du

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • China Postdoctoral Science Foundation
  • Guangzhou Municipal Science and Technology Program key projects
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Li, J. X., Shu, N., Zhang, Y. J., Tong, Q. S., Wang, L., Zhang, J. Y., & Du, J. Z. (2024). Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c01563

Vancouver

Li JX, Shu N, Zhang YJ, Tong QS, Wang L, Zhang JY, et al. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c01563

BibTeX
@article{Li2024,
  author = {Li, Jia-Xian and Shu, Na and Zhang, Yao-Jun and Tong, Qi-Song and Wang, Ling and Zhang, Jing-Yang and Du, Jin-Zhi},
  title = {Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c01563}
}
Kostenlos starten →